Pages that link to "Q34006269"
Jump to navigation
Jump to search
The following pages link to Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. (Q34006269):
Displaying 50 items.
- Systematic analysis of off-target effects in an RNAi screen reveals microRNAs affecting sensitivity to TRAIL-induced apoptosis (Q21267232) (← links)
- Inhibition of vacuolar ATPase attenuates the TRAIL-induced activation of caspase-8 and modulates the trafficking of TRAIL receptosomes (Q24292952) (← links)
- Adherens junction protein nectin-4 is the epithelial receptor for measles virus (Q24295305) (← links)
- (Q24299363) (← links)
- Apo2L/TRAIL and the death receptor 5 agonist antibody AMG 655 cooperate to promote receptor clustering and antitumor activity (Q24301064) (← links)
- Modulation of the CD95-Induced Apoptosis: The Role of CD95 N-Glycosylation (Q24305009) (← links)
- Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling (Q24308725) (← links)
- Glycopeptide-preferring polypeptide GalNAc transferase 10 (ppGalNAc T10), involved in mucin-type O-glycosylation, has a unique GalNAc-O-Ser/Thr-binding site in its catalytic domain not found in ppGalNAc T1 or T2 (Q24312926) (← links)
- Hallmarks of glycosylation in cancer (Q26752363) (← links)
- Onto better TRAILs for cancer treatment (Q26768160) (← links)
- DED or alive: assembly and regulation of the death effector domain complexes (Q26796544) (← links)
- Mesenchymal stem cells as vectors for lung cancer therapy (Q26853498) (← links)
- Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family (Q26864268) (← links)
- Apoptotic agents (Q27016160) (← links)
- Getting TRAIL back on track for cancer therapy (Q27027460) (← links)
- Oral Supplementation of Glucosamine Fails to Alleviate Acute Kidney Injury in Renal Ischemia-Reperfusion Damage (Q27325815) (← links)
- Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5 (Q27649718) (← links)
- Caspase-8 expression is predictive of tumour response to death receptor 5 agonist antibody in Ewing's sarcoma (Q27853200) (← links)
- Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma (Q28069952) (← links)
- Fascin is regulated by slug, promotes progression of pancreatic cancer in mice, and is associated with patient outcomes (Q28306591) (← links)
- Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells (Q28391040) (← links)
- Ginsenoside compound K sensitizes human colon cancer cells to TRAIL-induced apoptosis via autophagy-dependent and -independent DR5 upregulation (Q28394059) (← links)
- Gene Expression Ratios Lead to Accurate and Translatable Predictors of DR5 Agonism across Multiple Tumor Lineages (Q28548165) (← links)
- ST6Gal-I Regulates Macrophage Apoptosis via α2-6 Sialylation of the TNFR1 Death Receptor (Q28579333) (← links)
- Lectin domains of polypeptide GalNAc transferases exhibit glycopeptide binding specificity (Q28740409) (← links)
- Aberrant DR5 transport through disruption of lysosomal function suggests a novel mechanism for receptor activation (Q28817289) (← links)
- Caspase-8 activation by TRAIL monotherapy predicts responses to IAPi and TRAIL combination treatment in breast cancer cell lines (Q30398758) (← links)
- Simultaneous profiling of 194 distinct receptor transcripts in human cells (Q30411399) (← links)
- Modulating cell-to-cell variability and sensitivity to death ligands by co-drugging (Q30544925) (← links)
- Constitutive localization of DR4 in lipid rafts is mandatory for TRAIL-induced apoptosis in B-cell hematologic malignancies. (Q30571484) (← links)
- Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin). (Q30576902) (← links)
- Lineage-specific roles of the cytoplasmic polyadenylation factor CPEB4 in the regulation of melanoma drivers (Q30829456) (← links)
- Conservation of peptide acceptor preferences between Drosophila and mammalian polypeptide-GalNAc transferase ortholog pairs (Q30845587) (← links)
- An untargeted multi-technique metabolomics approach to studying intracellular metabolites of HepG2 cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (Q31012928) (← links)
- A gene expression signature of invasive potential in metastatic melanoma cells (Q33521237) (← links)
- XIAP is not required for human tumor cell survival in the absence of an exogenous death signal (Q33523404) (← links)
- N-Acetylgalactosaminyltransferase-14 as a potential biomarker for breast cancer by immunohistochemistry (Q33548177) (← links)
- Protein kinase Cbeta modulates ligand-induced cell surface death receptor accumulation: a mechanistic basis for enzastaurin-death ligand synergy. (Q33569854) (← links)
- Networks and pathways in pigmentation, health, and disease (Q33584524) (← links)
- ONC201 activates ER stress to inhibit the growth of triple-negative breast cancer cells (Q33591623) (← links)
- C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2. (Q33688535) (← links)
- Plasminogen activator urokinase expression reveals TRAIL responsiveness and supports fractional survival of cancer cells (Q33695003) (← links)
- GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma (Q33710048) (← links)
- Targeting a novel N-terminal epitope of death receptor 5 triggers tumor cell death (Q33726537) (← links)
- Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors (Q33799792) (← links)
- Bortezomib sensitizes human renal cell carcinomas to TRAIL apoptosis through increased activation of caspase-8 in the death-inducing signaling complex. (Q33862527) (← links)
- Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathways (Q33907593) (← links)
- DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas. (Q33939106) (← links)
- The role of mucin-type O-glycans in eukaryotic development (Q33987647) (← links)
- Combination therapy with anti-DR5 antibody and tamoxifen for triple negative breast cancer. (Q33989940) (← links)